Pharma & Healthcare
Phenylketonuria (PKU)
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
- Types
- Medications · Supplements · Others
- Applications
- Household · Hospital
5 editions22 December 2025
$3,950Single user · USD · Market StructureExplore product: Phenylketonuria (PKU)Compare research options for Phenylketonuria (PKU)